With one week to go in 2015, there are still a few big pharmaceutical deals in the works. Shire plc (NASDAQ: SHPG) is now in friendly talks to take over Baxalta International Inc. (NYSE: BXLT) for a price rumored to be above $30 billion. By who’s waiting for 2016? Here is a preliminary tally of the year in pharmaceutical M&A, and how it compares to previous years. Spoiler alert: 2015 is another record year in dollar value.
Pharmaceutical M&A, 2011 to 2015*
|Deal value||$44.1 billion||$38.1 billion||$66.7 billion||$213.3 billion||$297.4 billion|
|*= thru Dec. 23|